NCT06648863

Brief Summary

The goal of this observational study is to learn about typical neurodevelopment in children aged 6 months to 5 years who live in Bahir Dar, Ethiopia. The main aims of the study are: Aim 1: To characterize typical neurodevelopment as measured by i) brain volume using low-field MRI and ii) scores on behavioral assessments of early child neurodevelopment. Aim 2: To characterize typical pre-academic school skills in early childhood as measured by tasks of visual processing, reasoning, verbal expression and school readiness. Aim 3: To identify factors influencing child development in a community in Bahir Dar, Amhara region of Ethiopia, as measured by validated measures of maternal mental health, home environment, and childhood adversity. Participants will complete one low-field MRI scan at enrollment, have a hemoglobin blood test, and undergo age-appropriate neurodevelopmental assessments and surveys that may include:

  • WHO Global Scales for Early Development (GSED) \[ages 6 - 36 months\]
  • Tasks of visual reasoning and verbal expression \[ages 48-60 months\]
  • Executive Functions test using the tablet-based NIH Toolbox \[ages 48-60 months\]
  • School Readiness questionnaire assessing knowledge of literacy, numeracy, early reading, crystallized knowledge, memory, and self-regulation \[ages 48-60 months\]
  • Maternal report of child's motor, cognitive and socioemotional skillsChild Anthropometrics assessment Additional assessments of the participant's family and environment will include
  • Medical History questionnaire
  • Family socioeconomic status
  • Maternal Mental Health
  • Recent Life Events and hardship
  • Home Environment and Parenting UNICEF's MICs Family Care Indicators)
  • Food security and feeding practices

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
471

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 29, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 8, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 18, 2024

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2024

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

7 months

First QC Date

October 8, 2024

Last Update Submit

March 9, 2026

Conditions

Keywords

NeurodevelopmentAfricaCross-sectional

Outcome Measures

Primary Outcomes (1)

  • Total Brain MRI volumes

    Total supratentorial brain volume measured from Hyperfine MRI uzing standard processing pipelines for infant MRI progressing. Outcomes will be reported in cm3.

    Collected in all children (ages 6-60 months) at enrollment.

Secondary Outcomes (8)

  • WHO Global Scales for Early Development (GSED)

    Collected in children aged 6-36 months at enrollment.

  • Visual reasoning

    Collected in children aged 48-60 months at enrollment.

  • School readiness

    Collected in children aged 48-60 months at enrollment.

  • Executive Functioning: cognitive flexibility and attention

    Collected in children aged 48-60 months at enrollment.

  • Self-regulation

    Collected in children aged 48-60 months at enrollment.

  • +3 more secondary outcomes

Study Arms (8)

A/6 months

Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI

B/12 months

Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI

C/18 months

Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI

D/24 months

Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI

E/30 months

Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI

F/36 months

Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI

G/48 months

Measures of child neurocognitive development and school readiness, nutrition, medical history, and anthropometrics followed by MRI

H/60 months

Measures of child neurocognitive development and school readiness, nutrition, medical history, and anthropometrics followed by MRI

Eligibility Criteria

Age6 Months - 60 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Children will be identified at rural health centers, outpatient vaccination clinics or campaigns, and other health facilities around Bahir Dar, Amhara, Ethiopia.

You may qualify if:

  • Children living in Bahir Dar town with parents who are willing and able to travel to Felege Hiwot Regional Hospital clinic for study visits
  • Healthy child without active clinical symptoms/complaints
  • Child within specified age ranges for each cohort/group (+/- 2 months)

You may not qualify if:

  • Child born with a severe congenital birth defect or hypoxic ischemic encephalopathy (birth asphyxia) per maternal report
  • Severe developmental or behavioral disorder per maternal report
  • Severe illness/clinical signs or symptoms of illness based on maternal and child report (including vomiting, headache, or seizures)
  • Plans to move out of catchment area in less than 1 year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Center

Bahir Dar, Addis, Ethiopia

Location

Related Publications (1)

  • Jensen SKG, Yibeltal K, North K, Workneh F, Teklehaimanot A, Abate BH, Fasil N, Melka TL, Chin TI, Folger LV, Roy Paladhi U, Van Dyk F, Thomason ME, Grant PE, Inder T, Worku A, Berhane Y, Lee AC. Bahir Dar Child Development Cross-Sectional Study, Ethiopia: study protocol. BMJ Paediatr Open. 2025 Apr 2;9(1):e003173. doi: 10.1136/bmjpo-2024-003173.

MeSH Terms

Conditions

Social Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Anne C Lee, MD, MPH

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR
  • Yemane Berhane, MD, PhD

    Addis Continental Institute of Public Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director Global Newborn Health

Study Record Dates

First Submitted

October 8, 2024

First Posted

October 18, 2024

Study Start

April 29, 2024

Primary Completion

November 11, 2024

Study Completion

December 1, 2024

Last Updated

March 11, 2026

Record last verified: 2026-03

Locations